Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.36 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL105113 | 0.95 | MAOB (0.35) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL31147816 | 0.92 | GAA (0.39) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL6107662 | 0.92 | GAA (0.39) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL7525719 | 0.91 | GAA (0.38) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL3288191 | 0.91 | ALOX5 (0.36) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL78795 | 0.90 | GAA (0.42) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL29664175 | 0.90 | GAA (0.42) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL9871781 | 0.90 | GAA (0.34) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL105838 | 0.89 | GAA (0.41) | GAAMAOBMAOAKMT2AMEN1 | |
| SCHEMBL9870753 | 0.89 | CNR1 (0.40) | GAAMAOBMAOAKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9034955-B2 | High molecular weight nonpolar benzotriazoles | BASF SE (DE) | 2015-05-19 | — | — | US | disclosed |
| US-9034955-B2 | High molecular weight nonpolar benzotriazoles | BASF SE (DE) | 2015-05-19 | — | — | US | disclosed |
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120059095-A1 | HIGH MOLECULAR WEIGHT NONPOLAR BENZOTRIAZOLES | SULT1A1, TPST2, SULT2A1 | GAA 1298/4885MAOB 73/4885MAOA 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.